These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12494801)

  • 1. [Use of midazolam in postoperative sedation of patients with multiple organ failure treated with hemodiafiltration. Clinical study and pharmacokinetics].
    Bastien O; Bolon M; Flamens C; Lehot JJ; Boulieu R
    Ann Fr Anesth Reanim; 2002 Nov; 21(9):692-7. PubMed ID: 12494801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous venovenous hemofiltration.
    Swart EL; de Jongh J; Zuideveld KP; Danhof M; Thijs LG; Strack van Schijndel RJ
    Am J Kidney Dis; 2005 Feb; 45(2):360-71. PubMed ID: 15685515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midazolam disposition in patients undergoing continuous venovenous hemodialysis.
    Bolon M; Bastien O; Flamens C; Paulus S; Boulieu R
    J Clin Pharmacol; 2001 Sep; 41(9):959-62. PubMed ID: 11549100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients.
    de Wildt SN; de Hoog M; Vinks AA; van der Giesen E; van den Anker JN
    Crit Care Med; 2003 Jul; 31(7):1952-8. PubMed ID: 12847388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of piperacillin in critically ill patients undergoing continuous venovenous hemofiltration.
    Capellier G; Cornette C; Boillot A; Guinchard C; Jacques T; Blasco G; Barale F
    Crit Care Med; 1998 Jan; 26(1):88-91. PubMed ID: 9428548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketamine and midazolam kinetics during continuous hemodiafiltration in patients with multiple organ dysfunction syndrome.
    Tsubo T; Sakai I; Okawa H; Ishihara H; Matsuki A
    Intensive Care Med; 2001 Jun; 27(6):1087-90. PubMed ID: 11497143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole.
    Muhl E; Martens T; Iven H; Rob P; Bruch HP
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):671-8. PubMed ID: 11214774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cefpirome in critically ill patients with renal failure treated by continuous veno-venous hemofiltration.
    Van der Werf TS; Fijen JW; Van de Merbel NC; Spanjersberg R; Möller AV; Ligtenberg JJ; Tulleken JE; Zijlstra JG; Stegeman CA
    Intensive Care Med; 1999 Dec; 25(12):1427-31. PubMed ID: 10660852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration.
    Giles LJ; Jennings AC; Thomson AH; Creed G; Beale RJ; McLuckie A
    Crit Care Med; 2000 Mar; 28(3):632-7. PubMed ID: 10752806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of long-term sufentanil infusion for sedation in ICU patients.
    Ethuin F; Boudaoud S; Leblanc I; Troje C; Marie O; Levron JC; Le Moing JP; Assoune P; Eurin B; Jacob L
    Intensive Care Med; 2003 Nov; 29(11):1916-20. PubMed ID: 12923616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between midazolam and remifentanil during monitored anesthesia care.
    Avramov MN; Smith I; White PF
    Anesthesiology; 1996 Dec; 85(6):1283-9. PubMed ID: 8968175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midazolam and its metabolites in brain death diagnosis.
    Meinitzer A; Zink M; März W; Baumgartner A; Halwachs-Baumann G
    Int J Clin Pharmacol Ther; 2005 Nov; 43(11):517-26. PubMed ID: 16300167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged sedation due to accumulation of conjugated metabolites of midazolam.
    Bauer TM; Ritz R; Haberthür C; Ha HR; Hunkeler W; Sleight AJ; Scollo-Lavizzari G; Haefeli WE
    Lancet; 1995 Jul; 346(8968):145-7. PubMed ID: 7603229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model.
    Barr J; Zomorodi K; Bertaccini EJ; Shafer SL; Geller E
    Anesthesiology; 2001 Aug; 95(2):286-98. PubMed ID: 11506097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midazolam infusion for basal sedation in intensive care: absence of accumulation.
    Michalk S; Moncorge C; Fichelle A; Huot O; Servin F; Farinotti R; Desmonts JM
    Intensive Care Med; 1988; 15(1):37-41. PubMed ID: 3230199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical study investigating the pharmacokinetic interaction between NN703 (tabimorelin), a potential inhibitor of CYP3A4 activity, and midazolam, a CYP3A4 substrate.
    Zdravkovic M; Olsen AK; Christiansen T; Schulz R; Taub ME; Thomsen MS; Rasmussen MH; Ilondo MM
    Eur J Clin Pharmacol; 2003 Feb; 58(10):683-8. PubMed ID: 12610745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of meropenem during continuous veno-venous haemofiltration and haemodiafiltration in patients with acute renal failure.
    Valtonen M; Tiula E; Backman JT; Neuvonen PJ
    J Antimicrob Chemother; 2000 May; 45(5):701-4. PubMed ID: 10797097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the CYP3A5 genotype on midazolam pharmacokinetics and pharmacodynamics during intensive care sedation.
    Fromm MF; Schwilden H; Bachmakov I; König J; Bremer F; Schüttler J
    Eur J Clin Pharmacol; 2007 Dec; 63(12):1129-33. PubMed ID: 17786417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated pharmacokinetics and pharmacodynamics of Ro 48-6791, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
    Dingemanse J; van Gerven JM; Schoemaker RC; Roncari G; Oberyé JJ; van Oostenbruggen MF; Massarella J; Segala P; Zell M; Cohen AF
    Br J Clin Pharmacol; 1997 Nov; 44(5):477-86. PubMed ID: 9384465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of acute changes in renal function on the pharmacokinetics of midazolam during long-term infusion in ICU patients.
    Driessen JJ; Vree TB; Guelen PJ
    Acta Anaesthesiol Belg; 1991; 42(3):149-55. PubMed ID: 1767626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.